The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors.
BACKGROUND:Metastatic breast cancer is the leading cause of cancer death in women, but the genomics of metastasis in breast cancer are poorly studied. METHODS:We explored a set of 11,616 breast tumors, including 5,034 metastases, which had undergone targeted sequencing during standard clinical care....
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0231999 |
id |
doaj-e81498c1e35142d48e4ab77d0cad9f43 |
---|---|
record_format |
Article |
spelling |
doaj-e81498c1e35142d48e4ab77d0cad9f432021-03-03T21:45:22ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01155e023199910.1371/journal.pone.0231999The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors.Jacob RinaldiEthan S SokolRyan J HartmaierSally E TrabuccoGarrett M FramptonMichael E GoldbergLee A AlbackerAnneleen DaemenGerard ManningBACKGROUND:Metastatic breast cancer is the leading cause of cancer death in women, but the genomics of metastasis in breast cancer are poorly studied. METHODS:We explored a set of 11,616 breast tumors, including 5,034 metastases, which had undergone targeted sequencing during standard clinical care. RESULTS:Besides the known hotspot mutations in ESR1, we observed a metastatic enrichment of previously unreported, lower-prevalence mutations in the ligand-binding domain, implying that these mutations may also be functional. Furthermore, individual ESR1 hotspots are significantly enriched in specific metastatic tissues and histologies, suggesting functional differences between these mutations. Other alterations enriched across all metastases include loss of function of the CDK4 regulator CDKN1B, and mutations in the transcription factor CTCF. Mutations enriched at specific metastatic sites generally reflect biology of the target tissue and may be adaptations to growth in the local environment. These include PTEN and ASXL1 alterations in brain metastases and NOTCH1 alterations in skin. We observed an enrichment of KRAS, KEAP1, STK11 and EGFR mutations in lung metastases. However, the patterns of other mutations in these tumors indicate that these are misdiagnosed lung primaries rather than breast metastases. CONCLUSIONS:An order-of-magnitude increase in samples relative to previous studies allowed us to detect novel genomic characteristics of metastatic cancer and to expand and clarify previous findings.https://doi.org/10.1371/journal.pone.0231999 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jacob Rinaldi Ethan S Sokol Ryan J Hartmaier Sally E Trabucco Garrett M Frampton Michael E Goldberg Lee A Albacker Anneleen Daemen Gerard Manning |
spellingShingle |
Jacob Rinaldi Ethan S Sokol Ryan J Hartmaier Sally E Trabucco Garrett M Frampton Michael E Goldberg Lee A Albacker Anneleen Daemen Gerard Manning The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors. PLoS ONE |
author_facet |
Jacob Rinaldi Ethan S Sokol Ryan J Hartmaier Sally E Trabucco Garrett M Frampton Michael E Goldberg Lee A Albacker Anneleen Daemen Gerard Manning |
author_sort |
Jacob Rinaldi |
title |
The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors. |
title_short |
The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors. |
title_full |
The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors. |
title_fullStr |
The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors. |
title_full_unstemmed |
The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors. |
title_sort |
genomic landscape of metastatic breast cancer: insights from 11,000 tumors. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2020-01-01 |
description |
BACKGROUND:Metastatic breast cancer is the leading cause of cancer death in women, but the genomics of metastasis in breast cancer are poorly studied. METHODS:We explored a set of 11,616 breast tumors, including 5,034 metastases, which had undergone targeted sequencing during standard clinical care. RESULTS:Besides the known hotspot mutations in ESR1, we observed a metastatic enrichment of previously unreported, lower-prevalence mutations in the ligand-binding domain, implying that these mutations may also be functional. Furthermore, individual ESR1 hotspots are significantly enriched in specific metastatic tissues and histologies, suggesting functional differences between these mutations. Other alterations enriched across all metastases include loss of function of the CDK4 regulator CDKN1B, and mutations in the transcription factor CTCF. Mutations enriched at specific metastatic sites generally reflect biology of the target tissue and may be adaptations to growth in the local environment. These include PTEN and ASXL1 alterations in brain metastases and NOTCH1 alterations in skin. We observed an enrichment of KRAS, KEAP1, STK11 and EGFR mutations in lung metastases. However, the patterns of other mutations in these tumors indicate that these are misdiagnosed lung primaries rather than breast metastases. CONCLUSIONS:An order-of-magnitude increase in samples relative to previous studies allowed us to detect novel genomic characteristics of metastatic cancer and to expand and clarify previous findings. |
url |
https://doi.org/10.1371/journal.pone.0231999 |
work_keys_str_mv |
AT jacobrinaldi thegenomiclandscapeofmetastaticbreastcancerinsightsfrom11000tumors AT ethanssokol thegenomiclandscapeofmetastaticbreastcancerinsightsfrom11000tumors AT ryanjhartmaier thegenomiclandscapeofmetastaticbreastcancerinsightsfrom11000tumors AT sallyetrabucco thegenomiclandscapeofmetastaticbreastcancerinsightsfrom11000tumors AT garrettmframpton thegenomiclandscapeofmetastaticbreastcancerinsightsfrom11000tumors AT michaelegoldberg thegenomiclandscapeofmetastaticbreastcancerinsightsfrom11000tumors AT leeaalbacker thegenomiclandscapeofmetastaticbreastcancerinsightsfrom11000tumors AT anneleendaemen thegenomiclandscapeofmetastaticbreastcancerinsightsfrom11000tumors AT gerardmanning thegenomiclandscapeofmetastaticbreastcancerinsightsfrom11000tumors AT jacobrinaldi genomiclandscapeofmetastaticbreastcancerinsightsfrom11000tumors AT ethanssokol genomiclandscapeofmetastaticbreastcancerinsightsfrom11000tumors AT ryanjhartmaier genomiclandscapeofmetastaticbreastcancerinsightsfrom11000tumors AT sallyetrabucco genomiclandscapeofmetastaticbreastcancerinsightsfrom11000tumors AT garrettmframpton genomiclandscapeofmetastaticbreastcancerinsightsfrom11000tumors AT michaelegoldberg genomiclandscapeofmetastaticbreastcancerinsightsfrom11000tumors AT leeaalbacker genomiclandscapeofmetastaticbreastcancerinsightsfrom11000tumors AT anneleendaemen genomiclandscapeofmetastaticbreastcancerinsightsfrom11000tumors AT gerardmanning genomiclandscapeofmetastaticbreastcancerinsightsfrom11000tumors |
_version_ |
1714815338182344704 |